TB - JA DME

Drug or biological acquired with 340B drug pricing program discount, reported for informational purposes for select entities.

The TB modifier was established by CMS and is required for 340B participating entities for separately payable Part B drugs or biologicals acquired under the 340B Drug Pricing Program

• Effective for dates of service on/after January 1, 2024
• May be used effective immediately, in place of the JG modifier
• Required for use by all entities effective January 1, 2025

Resources

• FAQ: Medicare-FFS Program Billing 340B Modifiers under the Hospital Outpatient Prospective Payment System (OPPS) (cms.gov)
• 340B Drug Pricing Program | HRSA
• Inflation Rebates in Medicare (cms.gov)
• MLN4800856 - Medicare Part B Inflation Rebate Guidance: Use of the 340B Modifier (cms.gov)